Moderna has tasked Thermo Fisher Scientific with fill-finish, labeling and packaging duties for its mRNA vaccine at Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina, and Lonza, which has helped manufacture Moderna’s drug substance at a site in Visp, will also create a new line at its Geleen site in the Netherlands. Source: Fierce Biotech 2/6/21